Suven Pharmaceuticals announced the appointment of Vivek Sharma as the new Executive Chairman, effective September 20. He succeeds Vaidheesh Annaswamy who has decided to transition from the Board and becomes the Vice-Chair of Suven’s Advisory Council.
Vivek brings tremendous CDMO and leadership expertise to Suven, acquired across his roles as CEO of Piramal Pharma Solutions and as Chairman & CEO of Adare Pharma Solutions. He was also CEO of Decision Resources Group, a healthcare analytics company, and CEO of Saama, an AI clinical analytics company (2022-24).
In this role, Vivek will help build a stronger customer connection and further drive the global expansion of the platform. Vivek earned an Executive MBA from the Thunderbird School of Global Management. He is also a Chartered Accountant and a Certified Public Accountant (CPA).
“We are confident that the business will immensely benefit from Vivek’s many years of CDMO and leadership experience, enabling us to unlock many future growth opportunities,” said Pankaj Patwari, Non-Exec Director, Suven and Managing Director, Advent International
“This an exciting time for the CDMO industry, especially for Indian players. Within this landscape, Suven, with its track record and especially its technology capabilities, is well-placed to capture market tailwinds,” said Vivek.